Head to Head Comparison: Talkspace (OTCMKTS:TALK) vs. Pear Therapeutics (NASDAQ:PEAR)

Talkspace (OTCMKTS:TALKGet Rating) and Pear Therapeutics (NASDAQ:PEARGet Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation.

Valuation and Earnings

This table compares Talkspace and Pear Therapeutics’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Talkspace $113.67 million 2.36 -$62.74 million ($1.41) -1.23
Pear Therapeutics $4.21 million 65.93 -$65.14 million N/A N/A

Talkspace has higher revenue and earnings than Pear Therapeutics.

Volatility and Risk

Talkspace has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Comparatively, Pear Therapeutics has a beta of 0.06, meaning that its share price is 94% less volatile than the S&P 500.


This table compares Talkspace and Pear Therapeutics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Talkspace -60.31% -49.10% -40.27%
Pear Therapeutics N/A -289.70% -32.24%

Analyst Recommendations

This is a breakdown of current ratings for Talkspace and Pear Therapeutics, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Talkspace 0 4 2 0 2.33
Pear Therapeutics 0 1 5 0 2.83

Talkspace currently has a consensus target price of $4.73, indicating a potential upside of 173.60%. Pear Therapeutics has a consensus target price of $11.75, indicating a potential upside of 484.58%. Given Pear Therapeutics’ stronger consensus rating and higher possible upside, analysts clearly believe Pear Therapeutics is more favorable than Talkspace.

Institutional & Insider Ownership

49.5% of Talkspace shares are held by institutional investors. Comparatively, 53.7% of Pear Therapeutics shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.


Pear Therapeutics beats Talkspace on 7 of the 11 factors compared between the two stocks.

Talkspace Company Profile (Get Rating)

Talkspace, Inc. operates as a virtual behavior healthcare company. It delivers healthcare through encrypted web and mobile platform. The company offers treatment options for every need, including psychiatry or adolescent, individual, or couples therapy. The members can send text, video, and voice messages to their therapists and engage in live video sessions. Talkspace, Inc. is based in New York, New York.

Pear Therapeutics Company Profile (Get Rating)

Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.

Receive News & Ratings for Talkspace Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talkspace and related companies with MarketBeat.com's FREE daily email newsletter.